MGC Diagnostics Corporation (NASDAQ:MGCD) Files An 8-K Results of Operations and Financial ConditionItem 2.02
Results of Operations and Financial Condition
Results for Third Fiscal Quarter ended July 31, 2017
On September 6, 2017, MGC Diagnostics Corporation (the “Company”) issued a press release announcing its results for the fiscal 2017 Third quarter ended July 31, 2017. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.
The information provided to Item 2.02 of this Form 8-K is being furnished and is not “filed” for purposes of Section 18 of the Securities Act of 1934, and may not be deemed incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference in that filing.
|
Section 9 |
Financial Statements and Exhibits |
|
Section 9.01 |
Financial Statements and Exhibits |
(d)Exhibits
The following is furnished as an Exhibit to this Report:
|
Exhibit No. |
Description of Exhibit |
|
99.1 |
Press release dated September 6, 2017, reporting results for the fiscal 2017 third quarter ended July 31, 2017. |
MGC DIAGNOSTICS Corp ExhibitEX-99.1 2 EX-99.1_1.htm PRESS RELEASE DATED SEPTEMBER 6,…To view the full exhibit click here
About MGC Diagnostics Corporation (NASDAQ:MGCD)
MGC Diagnostics Corporation is a medical technology company. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. The Company operates in the manufacture and sale of cardiorespiratory diagnostic products segment. The Company’s product portfolio provides solutions for disease detection, integrated care, and wellness across the cardiorespiratory healthcare range. The Company sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals and university-based medical centers, among others. The Company’s cardiorespiratory diagnostic products measure flow and respiratory pressures and also analyzes the inhaled and exhaled gases, such as oxygen and carbon dioxide. The Company offers its products in various categories, such as Pulmonary Function Products (PFT), Gas Exchange Testing Products, Cycle Ergometers and Treadmills, and Electronic Medical Records Interfaces. MGC Diagnostics Corporation (NASDAQ:MGCD) Recent Trading Information
MGC Diagnostics Corporation (NASDAQ:MGCD) closed its last trading session up +0.19 at 8.20 with 4,275 shares trading hands.
